Related Experiment Videos
Cutaneous lupus erythematosus and autoimmune thyroiditis.
The British Journal of Dermatology
|July 1, 1979
Summary
Discontinuing chloroquine therapy in a patient with cutaneous lupus erythematosus and hypothyroidism can trigger a thyrotoxic crisis. This case highlights the critical link between lupus management and thyroid health.
Area of Science:
- Immunodermatology
- Endocrinology
- Pharmacology
Background:
- Cutaneous lupus erythematosus (CLE) is an autoimmune condition affecting the skin.
- Hypothyroidism is a common endocrine disorder characterized by insufficient thyroid hormone production.
- Chloroquine is a medication sometimes used in the management of certain autoimmune diseases.
Observation:
- A 19-year-old female patient was diagnosed with cutaneous lupus erythematosus and hypothyroidism.
- The patient was undergoing treatment that included chloroquine therapy.
- Thyrotoxic crisis, a life-threatening exacerbation of hyperthyroidism, developed upon cessation of chloroquine.
Findings:
- The discontinuation of chloroquine precipitated a severe thyrotoxic crisis in a patient with co-existing CLE and hypothyroidism.
- This suggests a potential role of chloroquine in modulating thyroid function or masking underlying thyroid instability in susceptible individuals.
- The case underscores the complex interplay between autoimmune disease management and endocrine regulation.
Implications:
- Clinicians should be vigilant for potential thyroid complications when initiating or discontinuing chloroquine in patients with autoimmune conditions.
- Further research is warranted to elucidate the precise mechanisms by which chloroquine may influence thyroid status.
- This case emphasizes the importance of comprehensive patient monitoring, particularly regarding endocrine function, during dermatological treatment regimens.